Shoddy biopsies deny cancer patients a shot at personalized treatment

A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren¹t robust enough to be put through genetic analysis. Keith Flaherty (Mass General) is leading the trial.

Read the full article